Surgical site infections and other postoperative complications following prophylactic anticoagulation in total joint arthroplasty

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Wang, Zhong ^a   Anderson Jr , Frederick A ^b   Ward, Michael ^a   Bhattacharyya, Timothy ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PROPENSITY SCORE; REOPERATION; RISK FACTOR; SCORING SYSTEM; SURGICAL INFECTION; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; ADOLESCENT; COHORT ANALYSIS; HIP ARTHROPLASTY; KNEE ARTHROPLASTY; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; REGISTER; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COHORT STUDIES; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; REGISTRIES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84899568730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091755     Document Type: Article

References (33)

1. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, et al. (2012) Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141: e278S-325S.
2. American Academy of Orthopedic Surgeons (2012) Guideline on Preventing Venous Thromboembolic Disease in Patients Undergoing Elective Hip and Knee Arthroplasty. http://www.aaos.org/research/guidelines/VTE/VTE-guideline.asp Accessed 25 January 2013
3. Lieberman JR, Hsu WK (2005) Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 87: 2097-2112. (Pubitemid 41279143)
4. Urquhart DM, Hanna FS, Brennan SL, Wluka AE, Leder K, et al. (2010) Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty 25: 1216-1222 e1211-1213.
5. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, et al. (2008) Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 23: 984-991.
6. Bozic KJ, Ries MD (2005) The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 87: 1746-1751. (Pubitemid 41061193)
7. Aquilina AL, Brunton LR, Whitehouse MR, Sullivan N, Blom AW (2012) Direct thrombin inhibitor (DTI) vs. aspirin in primary total hip and knee replacement using wound ooze as the primary outcome measure. A prospective cohort study. Hip Int 22: 22-27.
8. Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, et al. (2007) Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 89: 33-38. (Pubitemid 46059142)
9. Minnema B, Vearncombe M, Augustin A, Gollish J, Simor AE (2004) Risk factors for surgical-site infection following primary total knee arthroplasty. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 25: 477-480.
10. Asensio A, Ramos A, Munez E, Vilanova JL, Torrijos P, et al. (2005) Preoperative low molecular weight heparin as venous thromboembolism prophylaxis in patients at risk for prosthetic infection after knee arthroplasty. Infect Control Hosp Epidemiol 26: 903-909. (Pubitemid 43088871)
11. Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, et al. (2007) Does "excessive" anticoagulation predispose to periprosthetic infection? J Arthroplasty 22: 24-28. (Pubitemid 47332999)
12. Kwong LM, Kistler KD, Mills R, Wildgoose P, Klaskala W (2012) Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review. Expert Opin Pharmacother 13: 333-344.
13. Anderson FA Jr (2010) Overview of the GLOBAL Orthopaedic Registry (GLORY). Am J Orthop (Belle Mead NJ) 39: 2-4.
14. Hull R, Raskob G, Pineo G, Rosenbloom D, Evans W, et al. (1993) A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 329: 1370-1376. (Pubitemid 23317346)
15. Cushner F, Agnelli G, FitzGerald G, Warwick D (2010) Complications and functional outcomes after total hip arthroplasty and total knee arthroplasty: results from the Global Orthopaedic Registry (GLORY). Am J Orthop (Belle Mead NJ) 39: 22-28.
16. Friedman RJ, Gallus A, Gil-Garay E, FitzGerald G, Cushner F (2010) Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty-insights from the Multinational Global Orthopaedic Registry (GLORY). Am J Orthop (Belle Mead NJ) 39: 14-21.
17. Waddell J, Johnson K, Hein W, Raabe J, FitzGerald G, et al. (2010) Orthopaedic practice in total hip arthroplasty and total knee arthroplasty: results from the Global Orthopaedic Registry (GLORY). Am J Orthop (Belle Mead NJ) 39: 5-13.
18. Warwick D, Agnelli G, Cushner F, Friedman RJ, FitzGerald G, et al. (2010) Lessons learned from the global orthopaedic registry: study design, current practice patterns, and future directions. Am J Orthop (Belle Mead NJ) 39: 29-31.
19. Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70: 41-55.
20. Wang Z, Tobler S, Roayaei J, Eick A (2009) Live Attenuated or Inactivated Influenza Vaccines and Medical Encounters for Respiratory Illnesses Among US Military Personnel. Jama-Journal of the American Medical Association 301: 945-953.
21. Hu JC, Gu X, Lipsitz SR, Barry MJ, D'Amico AV, et al. (2009) Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy. JAMA: The Journal of the American Medical Association 302: 1557-1564.
22. Rubin DB (1987) Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley & Sons; 1987.
23. Little RJA, Rubin RD (2002) Statistical Analysis With Missing Data. 2nd ed Hoboken, NJ: Wiley Interscience; .
24. Raghunathan TE, Lepkowski LJ, Van Hoewyk J, Solenberger P (2001) A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 27: 85-95.
25. Seaman SR, White IR, Copas AJ, Li L (2012) Combining Multiple Imputation and Inverse-Probability Weighting. Biometrics 68: 129-137.
26. Jamsen E, Huhtala H, Puolakka T, Moilanen T (2009) Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am 91: 38-47.
27. Galat DD, McGovern SC, Hanssen AD, Larson DR, Harrington JR, et al. (2008) Early return to surgery for evacuation of a postoperative hematoma after primary total knee arthroplasty. J Bone Joint Surg Am 90: 2331-2336.
28. Galat DD, McGovern SC, Larson DR, Harrington JR, Hanssen AD, et al. (2009) Surgical treatment of early wound complications following primary total knee arthroplasty. J Bone Joint Surg Am 91: 48-54.
29. Saleh K, Olson M, Resig S, Bershadsky B, Kuskowski M, et al. (2002) Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res 20: 506-515. (Pubitemid 34464075)
30. Katz JN, Losina E, Barrett J, Phillips CB, Mahomed NN, et al. (2001) Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg Am 83-A: 1622-1629.
31. Novicoff WM, Brown TE, Cui Q, Mihalko WM, Slone HS, et al. (2008) Mandated venous thromboembolism prophylaxis: possible adverse outcomes. J Arthroplasty 23: 15-19.
32. Wang Z, Chen F, Ward M, Bhattacharyya T (2012) Compliance with surgical care improvement project measures and hospital-associated infections following hip arthroplasty. J Bone Joint Surg Am 94: 1359-1366.
33. Jameson SS, Rymaszewska M, Hui AC, James P, Serrano-Pedraza I, et al. (2012) Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty. J Bone Joint Surg Am 94: 1554-1558. Diseases